Determining post-operative morbidity and mortality following gynecological oncology surgery: protocol for a multicenter, international, prospective cohort study (Global Gynaecological Oncology Surgical Outcomes Collaborative-GO SOAR)
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články, multicentrická studie, práce podpořená grantem
PubMed
34489356
DOI
10.1136/ijgc-2021-002586
PII: S1048-891X(24)00474-2
Knihovny.cz E-zdroje
- Klíčová slova
- gynecologic surgical procedures, postoperative complications, surgical oncology,
- MeSH
- gynekologické chirurgické výkony mortalita MeSH
- kohortové studie MeSH
- lidé MeSH
- morbidita MeSH
- nádory ženských pohlavních orgánů mortalita chirurgie MeSH
- prospektivní studie MeSH
- výsledek terapie MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- práce podpořená grantem MeSH
BACKGROUND: The Global Gynaecological Oncology Surgical Outcomes Collaborative (GO SOAR) aims to develop a network of gynecological oncology surgeons, surgical departments, and other interested parties that will have the long-term ability to collaborate on outcome studies. The protocol for the first collaborative study is presented here. PRIMARY OBJECTIVE: To evaluate international variation in 30-day post-operative morbidity and mortality following gynecological oncology surgery between very high/high and medium/low human development index country settings. HYPOTHESIS: There is no variation in post-operative morbidity and mortality following gynecological oncology surgery between very high/high and medium/low human development index country settings. STUDY DESIGN: International, multicenter, prospective cohort study. Patient data will be collected over a consecutive 30-day period through gynecological oncology multidisciplinary teams/tumor boards and clinics across different human development index country groups. All data are collected on a customized, secure, password protected, central REDCap database. MAJOR INCLUSION/EXCLUSION CRITERIA: Inclusion criteria include women aged ≥18 years undergoing elective/emergency, curative/palliative surgery for primary/recurrent tubo-ovarian/peritoneal, endometrial, cervical, vulval, vaginal, gestational trophoblastic malignancies. Surgical modality may be open, minimal access (laparoscopic/robotic), or vaginal. PRIMARY ENDPOINT: 30-day post-operative morbidity and mortality defined as per Clavien-Dindo classification system. SAMPLE SIZE: 1100 (550/arm). ESTIMATED DATES FOR COMPLETING ACCRUAL AND PRESENTING RESULTS: It is estimated recruitment will be completed by 2022 and results published by 2023. TRIAL REGISTRATION: ClinicalTrials.gov registry: NCT04579861 (https://clinicaltrials.gov/ct2/show/NCT04579861).
Aberdeen Health Data Science Research Centre University of Aberdeen Aberdeen UK
Department of Gynaecological Oncology Cancer Diseases Hospital Lusaka Zambia
Department of Gynecologic Oncology Northwestern University in Chicago Evanston Illinois USA
Department of Obstetrics and Gynaecology General University Hospital Prague Czech Republic
Institute of Applied Health Sciences University of Aberdeen Aberdeen UK
School of Physics Engineering and Computer Science University of Hertfordshire Hatfield UK
Citace poskytuje Crossref.org
ClinicalTrials.gov
NCT04579861